DYN – dyne therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Dyne Therapeutics (DYN) had its price target lowered by HC Wainwright from $60.00 to $50.00. They now have a "buy" rating on the stock.
Dyne Therapeutics (DYN) was given a new $38.00 price target by Chardan Capital.
Investment Firm Adds Nearly $4 Milllion Worth of DYN Shares, According to Recent SEC Filing [Yahoo! Finance]
Dyne Therapeutics (DYN) had its "overweight" rating reaffirmed by Morgan Stanley.
Dyne Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights [Yahoo! Finance]
Form 4 Dyne Therapeutics, Inc. For: Mar 05 Filed by: Friedl-Naderer Johanna
Form 4 Dyne Therapeutics, Inc. For: Mar 05 Filed by: Kerr Douglas
Form 4 Dyne Therapeutics, Inc. For: Mar 05 Filed by: Cox John
Form SCHEDULE 13G/A Dyne Therapeutics, Inc. Filed by: T. Rowe Price Investment Management, Inc.
Form 144 Dyne Therapeutics, Inc. Filed by: Cox John
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.